-
Bristol-Myers Squibb Company (BMY)
-
Knight Therapeutics Inc. (GUD)
-
iShares U.S. Medical Devices ETF (IHI)
Q: I have an average price on BMY shares of $69 having bought near peak price...when the recommendations by other analysts ( not 5i) were extremely positive. After, the company missed expectations with a drug and the downfall began. Now, I am wondering, what factors would you consider in making the decision whether to exit this losing trade and put the $$ into an alternate pharm company such as GUD or an ETF such as some you have recently mentioned IHI.